Question:
We are a scientific medical-tech company. Similar companies often use their 'prominent scientists' who are behind the various technologies to advocate their products.
Look at ASX:RAP... Bugger all revenue, no certainty people will even use telehealth (doctors aren't in a rush to get involved - nor are patients... have you tried to use telehealth..?). Yet, their directors are constantly in the media drumming up attention for their technology/company.
Could we lean on Prof Ian Frazer to do more to 'advocate' the immunotherapies division of Admedus? This is the division most struggling, so it needs something to help attract capital...
Questions for AGM?, page-109
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |